195 related articles for article (PubMed ID: 16829540)
1. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization.
Niccoli G; Lanza GA; Shaw S; Romagnoli E; Gioia D; Burzotta F; Trani C; Mazzari MA; Mongiardo R; De Vita M; Rebuzzi AG; Lüscher TF; Crea F
Eur Heart J; 2006 Aug; 27(15):1793-8. PubMed ID: 16829540
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging.
Eitel I; Nowak M; Stehl C; Adams V; Fuernau G; Hildebrand L; Desch S; Schuler G; Thiele H
Am Heart J; 2010 May; 159(5):882-90. PubMed ID: 20435200
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.
Niccoli G; Giubilato S; Russo E; Spaziani C; Leo A; Porto I; Leone AM; Burzotta F; Riondino S; Pulcinelli F; Biasucci LM; Crea F
Eur Heart J; 2008 Aug; 29(15):1843-50. PubMed ID: 18617477
[TBL] [Abstract][Full Text] [Related]
4. Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction.
Niccoli G; Lanza GA; Spaziani C; Altamura L; Romagnoli E; Leone AM; Fusco B; Trani C; Burzotta F; Mazzari MA; Mongiardo R; Biasucci LM; Rebuzzi AG; Crea F
Int J Cardiol; 2007 May; 117(3):306-11. PubMed ID: 16859772
[TBL] [Abstract][Full Text] [Related]
5. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty.
Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Huczek Z; Horszczaruk GJ; Kochman J; Rudowski R; Opolski G
Am Heart J; 2004 Oct; 148(4):655-62. PubMed ID: 15459597
[TBL] [Abstract][Full Text] [Related]
6. Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry.
Lee CH; Wong HB; Tan HC; Zhang JJ; Teo SG; Ong HY; Low A; Sutandar A; Lim YT
J Interv Cardiol; 2005 Aug; 18(4):261-6. PubMed ID: 16115155
[TBL] [Abstract][Full Text] [Related]
7. Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation?
Schäfer U; Kurz T; Jain D; Hartmann F; Dendorfer A; Tölg R; Raasch W; Dominiak P; Katus H; Richardt G
Basic Res Cardiol; 2002 Sep; 97(5):399-408. PubMed ID: 12200640
[TBL] [Abstract][Full Text] [Related]
8. Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarction.
Kandzari DE; Tcheng JE; Gersh BJ; Cox DA; Stuckey T; Turco M; Mehran R; Garcia E; Zimetbaum P; McGlaughlin MG; Lansky AJ; Costantini CO; Grines CL; Stone GW;
Am Heart J; 2006 Jun; 151(6):1288-95. PubMed ID: 16781238
[TBL] [Abstract][Full Text] [Related]
9. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
[TBL] [Abstract][Full Text] [Related]
10. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
Celik T; Iyisoy A; Yuksel CU; Kilic S; Yilmaz MI; Akgul EO; Jata B; Isik E
Coron Artery Dis; 2008 Dec; 19(8):543-9. PubMed ID: 19005288
[TBL] [Abstract][Full Text] [Related]
11. Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention.
Ege M; Güray U; Güray Y; Yılmaz MB; Demirkan B; Saşmaz A; Korkmaz S
Anadolu Kardiyol Derg; 2011 May; 11(3):213-7. PubMed ID: 21421510
[TBL] [Abstract][Full Text] [Related]
12. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
[TBL] [Abstract][Full Text] [Related]
13. Intracoronary nitroprusside in the prevention of the no-reflow phenomenon in acute myocardial infarction.
Pan W; Wang LF; Yu JH; Fan Y; Yang SS; Zhou LJ; Li Y; Li WM
Chin Med J (Engl); 2009 Nov; 122(22):2718-23. PubMed ID: 19951602
[TBL] [Abstract][Full Text] [Related]
14. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
Sorajja P; Gersh BJ; Cox DA; McLaughlin MG; Zimetbaum P; Costantini C; Stuckey T; Tcheng JE; Mehran R; Lansky AJ; Grines CL; Stone GW
Eur Heart J; 2007 Jul; 28(14):1709-16. PubMed ID: 17556348
[TBL] [Abstract][Full Text] [Related]
15. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
[TBL] [Abstract][Full Text] [Related]
16. Impact of primary percutaneous coronary intervention on blood perfusion in nonculprit artery in patients with anterior ST elevation myocardial infarction.
Wang J; Liu JH; Zheng B; Zhang M; Wang SP; Zheng Z
Chin Med J (Engl); 2013 Jan; 126(1):22-6. PubMed ID: 23286472
[TBL] [Abstract][Full Text] [Related]
17. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study.
Tanaka A; Imanishi T; Kitabata H; Kubo T; Takarada S; Tanimoto T; Kuroi A; Tsujioka H; Ikejima H; Komukai K; Kataiwa H; Okouchi K; Kashiwaghi M; Ishibashi K; Matsumoto H; Takemoto K; Nakamura N; Hirata K; Mizukoshi M; Akasaka T
Eur Heart J; 2009 Jun; 30(11):1348-55. PubMed ID: 19383736
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of percutaneous coronary intervention for infarct-related artery only or for both infarct- and non-infarct-related arteries in patients with ST-elevation myocardial infarction and multi-vessel disease.
Han YL; Wang B; Wang XZ; Li Y; Wang SL; Jing QM; Wang G; Ma YY; Luan B
Chin Med J (Engl); 2008 Dec; 121(23):2384-7. PubMed ID: 19102953
[TBL] [Abstract][Full Text] [Related]
19. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].
Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N
Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
